Trump order directs federal agencies to reclassify marijuana from Schedule I to Schedule III, reshaping federal drug policy
The order aims to accelerate medical research by reclassifying marijuana to Schedule III, potentially saving cannabis companies $800 million annually, while maintaining federal restrictions.
- On Dec. 18, President Donald Trump signed an executive order in the Oval Office to reschedule marijuana from Schedule I to Schedule III with `Today, I'm pleased to announce that I will be signing an executive order to reschedule marijuana from a schedule one to a schedule three controlled substance with legitimate medical uses`, Trump said.
- Since 1970, marijuana was classified as Schedule I with no accepted medical use, while President Joe Biden's review and a 2024 proposed rescheduling rule stalled.
- Industry groups say rescheduling could lower tax burdens, ease banking, and expand research access, while premarket trading showed Tilray shares up nearly 5% and SNDL rising 3%.
- The order directs Attorney General Pam Bondi to hasten rescheduling without a timeline, officials stressed it "is not the legalization" and asks aides to work with Congress and HHS on CBD access and Medicare CBD pilot consideration.
- Advocates welcomed the order and said it enables evidence-based discussions, while Nash County Sheriff Keith Stone raised safety concerns and Florida's 2024 ballot initiative failed despite nearly 56% support.
496 Articles
496 Articles
According to the president, many people have been pleading for the expansion of the use of cannabis, especially those who struggle with illnesses that cause great pain.
US President Donald Trump has signed an executive order designating marijuana as a less dangerous drug at the federal level, which does not legalize it at the federal level, but allows for medical research, reduces the tax burden on the cannabis industry, and simplifies regulation.
'It's tremendous': President Trump signs executive order to ease marijuana restrictions
President Donald Trump signed an executive order Thursday to expedite the reclassification of marijuana from a Schedule One drug to Schedule Three, potentially opening doors for expanded medical research and easing business operations for dispensaries.Currently, marijuana is classified alongside heroin, LSD and ecstasy as a Schedule One substance. The reclassification would allow for medical use and make research significantly easier for medical…
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium





































